Use of a sprayed fibrin hemostatic sealant after laser therapy for hereditary hemorrhagic telangiectasia epistaxis

American Journal of Rhinology

Volumn 21, Issue 2, 2007, Pages 187-191

  Richmon, Jeremy D ^a   Tian, Ying ^a   Husseman, Jacob ^a   Davidson, Terence M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Crosseal; Epistaxis; Evicel; Hereditary hemorrhagic telangiectasia; Human fibrin sealant; Nasal packing; Olser Weber Rendu; Treatment outcome

Indexed keywords

FIBRIN; HEMOSTATIC AGENT; SEALANT;

ADULT; AEROSOL; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EPISTAXIS; FEMALE; HOSPITAL CHARGE; HOSPITAL READMISSION; HUMAN; LOW LEVEL LASER THERAPY; MAJOR CLINICAL STUDY; MALE; NOSE MUCOSA; POSTOPERATIVE COMPLICATION; RENDU OSLER WEBER DISEASE; UNITED STATES; UNIVERSITY HOSPITAL;

ADULT; AGED; EPISTAXIS; FEMALE; FIBRIN TISSUE ADHESIVE; HEMOSTATICS; HUMANS; LASER SURGERY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TREATMENT OUTCOME;

EID: 34249821073     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/ajr.2007.21.2969     Document Type: Article

References (35)

1. Westermann CJ, Rosina AF, De Vries V, and de Coteau PA. The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: A family screening. Am J Med Genet A 116:324-328, 2003.
2. Porteous ME, Burn J, and Proctor SJ. Hereditary haemorrhagic telangiectasia: A clinical analysis. J Med Genet 29:527-530, 1992.
3. Berg J, Porteous M, Reinhardt D, et al. Hereditary haemorrhagic telangiectasia: A questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations. J Med Genet 40:585-590, 2003.
4. Cirulli A, Liso A, D'Ovidio F, et al. Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia. Acta Haematol 110:29-32, 2003.
5. Guttmacher AE, Marchuk DA, and White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 333:918-924, 1995.
6. Haitjema T, Balder W, Disch FJ, and Westermann CJ. Epistaxis in hereditary haemorrhagic telangiectasia. Rhinology 34:176-178, 1996.
7. OS AA, Friedman CM, and White RI Jr. The natural history of epistaxis in hereditary hemorrhagic telangiectasia. Laryngoscope 101:977-980, 1991.
8. Vitek J. Idiopathic intractable epistaxis: Endovascular therapy. Radiology 181:113-116, 1991.
9. Lund VJ, and Howard DJ. A treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasia. Am J Rhinol 13:319-322, 1999.
10. Byahatti SV, Rebeiz EE, and Shapshay SM. Hereditary hemorrhagic telangiectasia: What the otolaryngologist should know. Am J Rhinol 11:55-62, 1997.
11. Kluger PB, Shapshay SM, Hybels RL, and Bohigian RK. Neodymium-YAG laser intranasal photocoagulation in hereditary hemorrhagic telangiectasia: An update report. Laryngoscope 97:1397-1401, 1987.
12. Flessa HC, and Glueck HI. Hereditary hemorrhagic telangiectasia (Osier-Weber-Rendu disease). Management of epistaxis in nine patients using systemic hormone therapy. Arch Otolaryngol 103:148-151, 1977.
13. Mehta AC, Livingston DR, and Levine HL. Fiberoptic bronchoscope and Nd-YAG laser in treatment of severe epistaxis from nasal hereditary hemorrhagic telangectasia and hemangioma. Chest 91:791-792, 1987.
14. Vaiman M, Eviatar E, Shlamkovich N, and Segal S. Effect of modern fibrin glue on bleeding after tonsillectomy and adenoidectomy. Ann Otol Rhinol Laryngol 112:410-414, 2003.
15. Vaiman M, Eviatar E, and Segal S. The use of fibrin glue as hemostatic in endonasal operations: A prospective, randomized study. Rhinology 40:185-188, 2002.
16. Vaiman M, Eviatar E, and Segal S. Effectiveness of second-generation fibrin glue in endonasal operations. Otolaryngol Head Neck Surg 126:388-391, 2002.
17. Vaiman M, Eviatar E, Shlamkovich N, and Segal S. Use of fibrin glue as a hemostatic in endoscopic sinus surgery. Ann Otol Rhinol Laryngol 114:237-241, 2005.
18. Vaiman M, Sarfaty S, Shlamkovich N, et al. Fibrin sealant: Alternative to nasal packing in endonasal operations. A prospective randomized study. Isr Med Assoc J 7:571-574, 2005.
19. Vaiman M, Martinovich U, Eviatar E, et al. Fibrin glue in initial treatment of epistaxis in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease). Blood Coagul Fibrinolysis 15:359-363, 2004.
20. Nanthakumar K, Graham AT, Robinson TI, et al. Contrast echocardiography for detection of pulmonary arteriovenous malformations. Am Heart J 141:243-246, 2001.
21. Fulbright RK, Chaloupka JC, Putman CM, et al. MR of hereditary hemorrhagic telangiectasia: Prevalence and spectrum of cerebrovascular malformations. AJNR Am J Neuroradiol 19:477-484, 1998.
22. Kjeldsen AD, and Kjeldsen J. Gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastroenterol 95:415-418, 2000.
23. Sharma VK, and Howden CW. Gastrointestinal and hepatic manifestations of hereditary hemorrhagic telangiectasia. Dig Dis 16:169-174, 1998.
24. Shah RK, Dhingra JK, and Shapshay SM. Hereditary hemorrhagic telangiectasia: A review of 76 cases. Laryngoscope 112:767-773, 2002.
25. Mahoney EJ, and Shapshay SM. Nd-YAG laser photocoagulation for epistaxis associated with hereditary hemorrhagic telangiectasia. Laryngoscope 115:373-375, 2005.
26. Bergler W, Riedel F, Baker-Schreyer A, et al. Argon plasma coagulation for the treatment of hereditary hemorrhagic telangiectasia. Laryngoscope 109:15-20, 1999.
27. Tierney PA, Samuel D, Patel KS, and Thomas DM. Audit of patient acceptance of nasal surgery as a day case procedure. Br J Clin Pract 50:357-359, 1996.
28. Weber R, Hochapfel F, and Draf W. Packing and stents in endonasal surgery. Rhinology 38:49-62, 2000.
29. Morgan NJ, Soo G, Frain I, and Nunez DA. Do ventilated packs reduce post-operative eustachian tube dysfunction? Clin Otolaryngol Allied Sci 20:411-412, 1995.
30. Kalogjera L, Pegan B, and Petric V. Adaptation to oral breathing after anterior nasal packing. Acta Otolaryngol 115:304-306, 1995.
31. Johannessen N, Jensen PF, Kristensen S, and Juul A. Nasal packing and nocturnal oxygen desaturation. Acta Otolaryngol Suppl 492:6-8, 1992.
32. Scheule AM, Beierlein W, Wendel HP, et al. Aprotinin in fibrin tissue adhesives induces specific antibody response and increases antibody response of high-dose intravenous application. J Thorac Cardiovasc Surg 118:348-353, 1999.
33. Dietrich W, Spath P, Zuhlsdorf M, et al. Anaphylactic reactions to aprotinin reexposure in cardiac surgery: Relation to antiaprotinin immunoglobulin G and E antibodies. Anesthesiology 95:64-71, 65A-66A, 2001.
34. Oswald AM, Joly LM, Gury C, et al. Fatal intraoperative anaphylaxis related to aprotinin after local application of fibrin glue. Anesthesiology 99:762-763, 2003.
35. Beierlein W, Scheule AM, Dietrich W, and Ziemer G. Forty years of clinical aprotinin use: A review of 124 hypersensitivity reactions. Ann Thorac Surg 79:741-748, 2005.